Physician profile

Ilona Barlam

Podiatrist · Redmond, WA

NPI 1780794834

$458.58

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$110.28

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Kerecis Limited $204.87 2021-2022
Smith+Nephew, INC. $52.43 2021-2023 Grafix
Orthofix Medical, INC. $51.19 2022
Next Science LLC $31.15 2023 Xperience, Blastx, Surgx
Invictus Surgical Incorporated $28.56 2024
Sandoz INC. $24.56 2019
Horizon Therapeutics Plc $17.31 2020
Organogenesis INC. $16.96 2021
Mimedx Group, INC. $16.65 2024
Abbott Laboratories $14.90 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Ilona Barlam

$458.58

in general payments reported 2019-2025

Years
2019-2024
Top company
Kerecis Limited

https://glasscript.com/doctor/171541/ilona-barlam

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.